Adam K. Levin
Hogan Lovells US LLP
- Address of record
- Columbia Square, 555 13th Street, NW, Suite 10.103, Washington, DC 20004-1109, 202-637-6846
- Phone
- (202) 637-6846
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
OptumRx TCPA Clinical Adherence Calls Settlement
OptumRx, Inc. placed clinical adherence calls using artificial or prerecorded voices to cellular telephone numbers and VOIP lines of non-customers, other than prescription refill reminders or COVID-19 vaccine calls, from April 20, 2020 through October 22, 2025. The settlement resolves alleged Telephone Consumer Protection Act (TCPA) claims arising from these calls.
- Settlement fund
- $1.9M
- Claim deadline
- February 4, 2026
- Represents
- OPTUMRX, INC.
EpiPen (Epinephrine) Pricing Settlement
Mylan Pharmaceuticals and Pfizer engaged in pricing and marketing practices for EpiPens that were allegedly anticompetitive. The defendants are settling claims related to these practices, with total recoveries of $609 million to class members ($345 million from Pfizer and $264 million from Mylan as of February 2022).
- Settlement fund
- $609M
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.